Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia.
about
Therapeutic Approaches Targeting MYC-Driven Prostate CancerTargeting PIM kinase as a therapeutic strategy in human hepatoblastoma.Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.
P2860
Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@en
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@nl
type
label
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@en
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@nl
prefLabel
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@en
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@nl
P2093
P2860
P1433
P1476
Protein profiling identifies m ...... 08, in acute myeloid leukemia.
@en
P2093
Ji-Yeon Yang
Lisa S Chen
Varsha Gandhi
P2860
P304
P356
10.3109/10428194.2016.1166489
P577
2016-04-07T00:00:00Z